Evidence map›Paper›PMID 14581570›Full record

ArticleJournal of virology2003

Genetic and functional analysis of full-length human immunodeficiency virus type 1 env genes derived from brain and blood of patients with AIDS.

Asa Ohagen, Amy Devitt, Kevin J Kunstman, Paul R Gorry, Patrick P Rose, Bette Korber, Joann Taylor, Robert Levy, Robert L Murphy, Steven M Wolinsky and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 96 papers.

0numbers the graph read from it
0cells of the map it votes in
96citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

96 citing papers in PubMed, 152 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

36 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Asa OhagenDepartment of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Amy Devitt
Kevin J Kunstman
Paul R Gorry
Patrick P Rose
Bette Korber
Joann Taylor
Robert Levy
Robert L Murphy
Steven M Wolinsky
Dana Gabuzda
Dana-Farber Cancer Institute · USHarvard University · USLos Alamos National Laboratory · USNorthwestern University · USSanta Fe Institute · US

Funding

DFCI-BIDMC-CH CENTER FOR AIDS RESEARCHP30AI028691 · NIAID · DANA-FARBER CANCER INSTITUTE · PI SODROSKI, JOSEPH G · 1989 to 2003
$6.2M
GREAT LAKES REGIONAL CENTER FOR AIDS RESEARCHP30CA079458 · NCI · NORTHWESTERN UNIVERSITY · PI WOLINSKY, STEVEN M · 1998 to 2002
$3.7M
CHEMOKINE RECEPTORS IN HIV1 INFECTION OF THE CNSR01NS037277 · NINDS · DANA-FARBER CANCER INSTITUTE · PI GABUZDA, DANA H. · 1998 to 2006
$2.9M
ROLE OF APOPTOSIS IN HIV-1 DEMENTIAR01NS035734 · NINDS · DANA-FARBER CANCER INSTITUTE · PI GABUZDA, DANA H. · 1996 to 2003
$1.4M
NCI NIH HHS CA79458NIAID NIH HHS AI28691NIAID NIH HHS P30 AI028691NIMHD NIH HHS L60 MD003100NINDS NIH HHS NS35734NINDS NIH HHS NS37277NINDS NIH HHS R01 NS035734NINDS NIH HHS R01 NS037277
6 · The paper itself

Abstract

The genetic evolution of human immunodeficiency virus type 1 (HIV-1) in the brain is distinct from that in lymphoid tissues, indicating tissue-specific compartmentalization of the virus. Few primary HIV-1 envelope glycoproteins (Envs) from uncultured brain tissues have been biologically well characterized. In this study, we analyzed 37 full-length env genes from uncultured brain biopsy and blood samples from four patients with AIDS. Phylogenetic analysis of intrapatient sequence sets showed distinct clustering of brain relative to blood env sequences. However, no brain-specific signature sequence was identified. Furthermore, there was no significant difference in the number or positions of N-linked glycosylation sites between brain and blood env sequences. The patterns of coreceptor usage were heterogeneous, with no clear distinction between brain and blood env clones. Nine Envs used CCR5 as a coreceptor, one used CXCR4, and two used both CCR5 and CXCR4 in cell-to-cell fusion assays. Eight Envs could also use CCR3, CCR8, GPR15, STRL33, Apj, and/or GPR1, but these coreceptors did not play a major role in virus entry into microglia. Recognition of epitopes by the 2F5, T30, AG10H9, F105, 17b, and C11 monoclonal antibodies varied among env clones, reflecting genetic and conformational heterogeneity. Envs from two patients contained 28 to 32 N-glycosylation sites in gp120, compared to around 25 in lab strains and well-characterized primary isolates. These results suggest that HIV-1 Envs in brain cannot be distinguished from those in blood on the basis of coreceptor usage or the number or positions of N-glycosylation sites, indicating that other properties underlie neurotropism. The study also demonstrates characteristics of primary HIV-1 Envs from uncultured tissues and implies that Env variants that are glycosylated more extensively than lab strains and well-characterized primary isolates should be considered during development of vaccines and neutralizing antibodies.

Indexed as

Genes, envAcquired Immunodeficiency SyndromeAmino Acid SequenceBrainCCR5 Receptor AntagonistsHIV-1HumansMolecular Sequence DataPhylogenyReceptors, CCR5Receptors, CXCR4Structure-Activity RelationshipViremiaVirus ReplicationCCR5 Receptor AntagonistsReceptors, CCR5Receptors, CXCR4

Identifiers

PMID14581570
PMCPMC254258
OpenAlexW2095637140

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.